Browse Data and Analysis

In September 2024, a National Assembly member submitted a draft revision of the Act on Transboundary Movements of Living Modified Organisms, commonly referred to as the LMO Act.

This report described Burma’s current production, regulations and trade for genetically engineered products, as well as recent activities focused on agricultural biotechnology. Burma’s (also called Myanmar) National Biosafety Framework and Biosafety Guidelines have been pending approval by the Ministry of Agriculture since before the 2021 coup.

Korea has not finalized the May 2021 revisions of its Living Modified Organism (LMO) Act, which defines Korea’s regulatory policies for products developed through innovative technologies including genome editing.

This report describes the status of Burma’s production and regulations for genetically engineered products and recent activities focused on agricultural biotechnology.

This report describes the status of Burma’s production, regulations, public attitudes, trading, and labeling requirements for genetic engineered products and the current activities for agricultural biotechnology.

The Republic of Korea (ROK) has joined international commitments to reach carbon neutrality by 2050 and passed a Carbon Neutrality Act in 2021 to promote green growth. Although the agricultural industry will be relatively less impacted than some other sectors (including energy), agricultural producers will need to make some adjustments.

Korea is in the process of revising its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

There are no significant developments to convey since the previous report from October 2020. Although Burma (also called Myanmar) does not yet have a comprehensive biosafety legislation, the final version of the National Biosafety Framework and Biosafety Guidelines are completed and pending approval.

Korea is in the process of drafting a proposal to revise its existing Living Modified Organism (LMO) Act to cover products of innovative biotechnologies, including genome edited products.

Although Burma (also called Myanmar) does not yet have a comprehensive biosafety legislation, the final version of the National Biosafety Framework is completed and pending approval...

In April 2019, the Rural Development Administration (RDA) announced the creation of its Center to Commercialize New Breeding Technologies.

There are no significant developments to convey since the previous report from November 2018.